Dimensional Fund Advisors’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Sell
270,740
-231,906
-46% -$231K ﹤0.01% 3013
2026
Q1
$353K Sell
502,646
-463,916
-48% -$433K ﹤0.01% 2993
2025
Q4
$1.5M Sell
966,562
-484,905
-33% -$775K ﹤0.01% 2790
2025
Q3
$2.29M Sell
1,451,467
-293,235
-17% -$510K ﹤0.01% 2737
2025
Q2
$3.8M Buy
1,744,702
+260,345
+18% +$630K ﹤0.01% 2597
2025
Q1
$4.05M Buy
1,484,357
+55,286
+4% +$218K ﹤0.01% 2557
2024
Q4
$5.94M Buy
1,429,071
+191,088
+15% +$722K ﹤0.01% 2485
2024
Q3
$4.82M Buy
1,237,983
+227,691
+23% +$959K ﹤0.01% 2527
2024
Q2
$3.96M Buy
1,010,292
+121,090
+14% +$521K ﹤0.01% 2572
2024
Q1
$3.73M Buy
889,202
+194,241
+28% +$912K ﹤0.01% 2619
2023
Q4
$3.27M Buy
694,961
+218,356
+46% +$850K ﹤0.01% 2669
2023
Q3
$1.49M Buy
+476,605
New +$1.92M ﹤0.01% 2844

Other funds holding MXCT

Dimensional Fund Advisors's MXCT Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its MaxCyte (MXCT) stake by 46% in Q2 2026, selling an estimated $231K and leaving 270,740 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #3013.

Dimensional Fund Advisors first reported a position in MXCT in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.94M in Q4 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Dimensional Fund Advisors held 270,740 shares of MaxCyte worth $333K as of Q2 2026.
  • Dimensional Fund Advisors sold 231,906 MaxCyte shares in Q2 2026, an estimated $231K.
  • MaxCyte made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3013 holding.
  • Dimensional Fund Advisors first reported a position in MaxCyte in Q3 2023 and has held it in 12 quarters since.
  • Dimensional Fund Advisors's MaxCyte position peaked at $5.94M in Q4 2024.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.